You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Go to Close Top


Avamys nasal spray is indicated for the treatment of the symptoms of allergic rhinitis 1

  • Avamys is indicated in adults, adolescents and children (6 years and over)

Get to know more about the journey of your allergic rhinitis patients

Shoji ENT Patient

Meet Shoji

  • 38-year-old bank manager with perennial AR
  • Symptoms include sneezing, nasal itching, congestion, and disturbed sleep
  • Despite an oral antihistamine, his symptoms persisted making it difficult to face clients at work
  • His doctor diagnosed moderate-to-severe AR

Find out how Avamys can help him

Anna GP Patient

Meet Anna

  • 32-year-old graphic designer
  • Currently using another nasal spray (OTC/Rx)
  • Experienced drip down of the nasal spray to the throat
  • Impacted her work and she was unable to cope with severity of her symptoms

Find out how Avamys can help her

Diego CHEST Patient

Meet James

  • 27-year-old PhD student
  • Has asthma and AR symptoms
  • Given additional asthma medications for AR symptoms
  • Worried he cannot complete PhD due to uncontrolled rhinitis affecting his concentration
  • Chest Physician diagnosed co-morbid, moderate AR

Find out how Avamys can help him

Ahmed PAED Patient

Meet Oliver

  • 8-year-old schoolboy
  • Has had to miss school and cannot go outside, missing his sports day
  • On an oral antihistamine but his symptoms remained uncontrolled

Find out how Avamys can help him

AR: Allergic rhinitis.
This is a hypothetical case study reflective of real-world experience.

Avamys is a registered trademark of the GlaxoSmithKline group of companies.